Bcl2 Modifying Factor Monoclonal Antibodies

Bcl2 Modifying Factor monoclonal antibodies

59 Bcl2 Modifying Factor monoclonal antibodies from 7 antibody suppliers Click each Bcl2 Modifying Factor monoclonal antibody that interests you to view the full Bcl2 Modifying Factor monoclonal antibody datasheet.

Western Blot - Use Filter to switch application

Supplier data
Origene TA807461S Bcl2 Modifying Factor antibody, TA807461S, Origene.

Mouse Mono [LN2], 30 ul
Hu, Mo, Rt
IHC-F, IHC-P, WB

IHC-F, IHC-P

Supplier data
Origene TA807685S Bcl2 Modifying Factor antibody, TA807685S, Origene.

Mouse Mono [OTI1H3], 30 ul
Hu, Mo, Rt
IHC-F, IHC-P, WB

IHC-F, IHC-P

Supplier data
Origene TA807513S Bcl2 Modifying Factor antibody, TA807513S, Origene.

Mouse Mono [By2], 30 ul
Hu, Mo, Rt
WB

Supplier data
Origene TA807524S Bcl2 Modifying Factor antibody, TA807524S, Origene.

Mouse Mono [OTI1G10], 30 ul
Hu, Mo, Rt
WB

Supplier data
Origene TA807459S Bcl2 Modifying Factor antibody, TA807459S, Origene.

Mouse Mono [OTI1G10], 30 ul
Hu, Mo, Rt
IHC-F, IHC-P, WB

IHC-F, IHC-P

Supplier data
Novus Biologicals NBP2-46578 Bcl2 Modifying Factor antibody, NBP2-46578, Novus Biologicals. Western Blot: BMF Antibody (6F3) [NBP2-46578] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF .

Bcl2 Modifying Factor antibody, NBP2-46578, Novus Biologicals. Western Blot: BMF Antibody (6F3) [NBP2-46578] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF .

Mouse Mono [6F3], 100 ul
Hu
IHC-F, IHC-P, WB

Bcl2 Modifying Factor antibody, NBP2-46578, Novus Biologicals, Immunohistochemistry frozen image

IHC-F,

Bcl2 Modifying Factor antibody, NBP2-46578, Novus Biologicals, Immunohistochemistry paraffin image

IHC-P

Supplier data
Enzo Life Sciences ALX-804-508-C100 Bcl2 Modifying Factor antibody, ALX-804-508-C100, Enzo Life Sciences. C) Detection of mouse and rat Bmf by Western blot using MAb to Bmf (17A9) (Prod. No. ALX-804-508). . D) Immunoprecipitation of endogenous Bmf from mouse spleen cells using MAb to Bmf (17A9) (Prod. No. ALX-804-508).

Bcl2 Modifying Factor antibody, ALX-804-508-C100, Enzo Life Sciences. C) Detection of mouse and rat Bmf by Western blot using MAb to Bmf (17A9) (Prod. No. ALX-804-508). . D) Immunoprecipitation of endogenous Bmf from mouse spleen cells using MAb to Bmf (17A9) (Prod. No. ALX-804-508).

Rat Mono [17A9], 100 ug
Mo, Rt
ELISA, FACS, IP, WB

ELISA,

Bcl2 Modifying Factor antibody, ALX-804-508-C100, Enzo Life Sciences, Flow Cytometry image

FACS, IP

Supplier data
Invitrogen Antibodies MA5-26878 Bcl2 Modifying Factor antibody, MA5-26878, Invitrogen Antibodies. Western blot analysis of BMF in HEK293T cells in untransfected (Left lane) and transfected (Right lane) samples using 5

Bcl2 Modifying Factor antibody, MA5-26878, Invitrogen Antibodies. Western blot analysis of BMF in HEK293T cells in untransfected (Left lane) and transfected (Right lane) samples using 5

Mouse Mono [OTI9B7], 100 ul
Hu
IHC-F, IHC-P, WB

Bcl2 Modifying Factor antibody, MA5-26878, Invitrogen Antibodies, Immunohistochemistry frozen image

IHC-F,

Bcl2 Modifying Factor antibody, MA5-26878, Invitrogen Antibodies, Immunohistochemistry paraffin image

IHC-P

Show/hide more from Origene

Supplier data
Origene TA807461 Bcl2 Modifying Factor antibody, TA807461, Origene.

Mouse Mono [Clone OTI9B7], 100 ul
Hu
IHC-F, IHC-P, WB

IHC-F, IHC-P

Supplier data
Origene TA807524 Bcl2 Modifying Factor antibody, TA807524, Origene.

Mouse Mono [Clone OTI4F4], 100 ul
Hu
WB

Supplier data
Origene CF807460 Bcl2 Modifying Factor antibody, CF807460, Origene.

Mouse Mono [Clone OTI3E5], 100 ug
Hu
IHC-F, IHC-P, WB

IHC-F, IHC-P

Supplier data
Origene CF807459 Bcl2 Modifying Factor antibody, CF807459, Origene.

Mouse Mono [Clone OTI6F3], 100 ug
Hu
IHC-F, IHC-P, WB

IHC-F, IHC-P

Supplier data
Origene CF807461 Bcl2 Modifying Factor antibody, CF807461, Origene.

Mouse Mono [Clone OTI9B7], 100 ug
Hu
IHC-F, IHC-P, WB

IHC-F, IHC-P

Supplier data
Origene CF807685 Bcl2 Modifying Factor antibody, CF807685, Origene.

Mouse Mono [Clone OTI3H5], 100 ug
Hu
IHC-F, IHC-P, WB

IHC-F, IHC-P

Supplier data
Origene TA807459 Bcl2 Modifying Factor antibody, TA807459, Origene.

Mouse Mono [Clone OTI6F3], 100 ul
Hu
IHC-F, IHC-P, WB

IHC-F, IHC-P

Supplier data
Origene TA807512 Bcl2 Modifying Factor antibody, TA807512, Origene.

Mouse Mono [Clone OTI5H2], 100 ul
Hu
WB

Supplier data
Origene CF807512 Bcl2 Modifying Factor antibody, CF807512, Origene.

Mouse Mono [Clone OTI5H2], 100 ug
Hu
WB

Supplier data
Origene CF807524 Bcl2 Modifying Factor antibody, CF807524, Origene.

Mouse Mono [Clone OTI4F4], 100 ug
Hu
WB

Supplier data
Origene TA807513 Bcl2 Modifying Factor antibody, TA807513, Origene.

Mouse Mono [Clone OTI7B3], 100 ul
Hu
WB

Supplier data
Origene TA807685 Bcl2 Modifying Factor antibody, TA807685, Origene.

Mouse Mono [Clone OTI3H5], 100 ul
Hu
IHC-F, IHC-P, WB

IHC-F, IHC-P

Supplier data
Origene CF807513 Bcl2 Modifying Factor antibody, CF807513, Origene.

Mouse Mono [Clone OTI7B3], 100 ug
Hu
WB

Supplier data
Origene TA807460 Bcl2 Modifying Factor antibody, TA807460, Origene.

Mouse Mono [Clone OTI3E5], 100 ul
Hu
IHC-F, IHC-P, WB

IHC-F, IHC-P

Supplier data
Invitrogen Antibodies MA5-26907 Bcl2 Modifying Factor antibody, MA5-26907, Invitrogen Antibodies. Western blot analysis of BMF in HEK293T cells in untransfected (Left lane) and transfected (Right lane) samples using 5

Bcl2 Modifying Factor antibody, MA5-26907, Invitrogen Antibodies. Western blot analysis of BMF in HEK293T cells in untransfected (Left lane) and transfected (Right lane) samples using 5

Mouse Mono [OTI3H5], 100 ul
Hu
IHC-F, IHC-P, WB

Bcl2 Modifying Factor antibody, MA5-26907, Invitrogen Antibodies, Immunohistochemistry frozen image

IHC-F,

Bcl2 Modifying Factor antibody, MA5-26907, Invitrogen Antibodies, Immunohistochemistry paraffin image

IHC-P

Supplier data
Invitrogen Antibodies MA5-26877 Bcl2 Modifying Factor antibody, MA5-26877, Invitrogen Antibodies. Western blot analysis of BMF in HEK293T cells in untransfected (Left lane) and transfected (Right lane) samples using 5

Bcl2 Modifying Factor antibody, MA5-26877, Invitrogen Antibodies. Western blot analysis of BMF in HEK293T cells in untransfected (Left lane) and transfected (Right lane) samples using 5

Mouse Mono [OTI3E5], 100 ul
Hu
IHC-F, IHC-P, WB

Bcl2 Modifying Factor antibody, MA5-26877, Invitrogen Antibodies, Immunohistochemistry frozen image

IHC-F,

Bcl2 Modifying Factor antibody, MA5-26877, Invitrogen Antibodies, Immunohistochemistry paraffin image

IHC-P

Supplier data
Lifespan Biosciences LS-C340280 Bcl2 Modifying Factor antibody, LS-C340280, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF (1:2000).

Bcl2 Modifying Factor antibody, LS-C340280, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF (1:2000).

Mouse Mono [OTI9B7], 1 Vial
Hu
IHC-F, IHC-P, WB

Bcl2 Modifying Factor antibody, LS-C340280, Lifespan Biosciences, Immunohistochemistry frozen image

IHC-F,

Bcl2 Modifying Factor antibody, LS-C340280, Lifespan Biosciences, Immunohistochemistry paraffin image

IHC-P

Supplier data
Lifespan Biosciences LS-C340278 Bcl2 Modifying Factor antibody, LS-C340278, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF (1:2000).

Bcl2 Modifying Factor antibody, LS-C340278, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF (1:2000).

Mouse Mono [OTI6F3], 1 Vial
Hu
IHC-F, IHC-P, WB

Bcl2 Modifying Factor antibody, LS-C340278, Lifespan Biosciences, Immunohistochemistry frozen image

IHC-F,

Bcl2 Modifying Factor antibody, LS-C340278, Lifespan Biosciences, Immunohistochemistry paraffin image

IHC-P

Supplier data
Lifespan Biosciences LS-C340279 Bcl2 Modifying Factor antibody, LS-C340279, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Bcl2 Modifying Factor antibody, LS-C340279, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Mouse Mono [OTI3E5], 1 Vial
Hu
IHC-F, IHC-P, WB

Bcl2 Modifying Factor antibody, LS-C340279, Lifespan Biosciences, Immunohistochemistry frozen image

IHC-F,

Bcl2 Modifying Factor antibody, LS-C340279, Lifespan Biosciences, Immunohistochemistry paraffin image

IHC-P

Supplier data
Lifespan Biosciences LS-C340365 Bcl2 Modifying Factor antibody, LS-C340365, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF (1:2000).

Bcl2 Modifying Factor antibody, LS-C340365, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF (1:2000).

Mouse Mono [OTI3H5], 1 Vial
Hu
IHC-F, IHC-P, WB

Bcl2 Modifying Factor antibody, LS-C340365, Lifespan Biosciences, Immunohistochemistry frozen image

IHC-F,

Bcl2 Modifying Factor antibody, LS-C340365, Lifespan Biosciences, Immunohistochemistry paraffin image

IHC-P

Supplier data
Lifespan Biosciences LS-C791255 Bcl2 Modifying Factor antibody, LS-C791255, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF. (1:2000)

Bcl2 Modifying Factor antibody, LS-C791255, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF. (1:2000)

Mouse Mono [LS-C791255], 1 Vial
Hu
IHC-F, IHC-P, WB

IHC-F,

Bcl2 Modifying Factor antibody, LS-C791255, Lifespan Biosciences, Immunohistochemistry paraffin image

IHC-P

Supplier data
Boster Biological Technology M02432 Bcl2 Modifying Factor antibody, M02432, Boster Biological Technology. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF (1:2000).

Bcl2 Modifying Factor antibody, M02432, Boster Biological Technology. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF (1:2000).

Mouse Mono [OTI6F3], 100 ul
Hu
IHC-F, IHC-P, WB

IHC-F,

Bcl2 Modifying Factor antibody, M02432, Boster Biological Technology, Immunohistochemistry paraffin image

IHC-P

Supplier data
Lifespan Biosciences LS-C791254 Bcl2 Modifying Factor antibody, LS-C791254, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF. (1:2000)

Bcl2 Modifying Factor antibody, LS-C791254, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF. (1:2000)

Mouse Mono [LS-C791254], 1 Vial
Hu
IHC-F, IHC-P, WB

IHC-F,

Bcl2 Modifying Factor antibody, LS-C791254, Lifespan Biosciences, Immunohistochemistry paraffin image

IHC-P

Supplier data
Lifespan Biosciences LS-C791252 Bcl2 Modifying Factor antibody, LS-C791252, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Bcl2 Modifying Factor antibody, LS-C791252, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Mouse Mono [LS-C791252], 1 Vial
Hu
IHC-F, IHC-P, WB

IHC-F,

Bcl2 Modifying Factor antibody, LS-C791252, Lifespan Biosciences, Immunohistochemistry paraffin image

IHC-P

Supplier data
Lifespan Biosciences LS-C791352 Bcl2 Modifying Factor antibody, LS-C791352, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF. (1:2000)

Bcl2 Modifying Factor antibody, LS-C791352, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF. (1:2000)

Mouse Mono [LS-C791352], 1 Vial
Hu
IHC-F, IHC-P, WB

IHC-F,

Bcl2 Modifying Factor antibody, LS-C791352, Lifespan Biosciences, Immunohistochemistry paraffin image

IHC-P

Supplier data
Lifespan Biosciences LS-C791287 Bcl2 Modifying Factor antibody, LS-C791287, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF. (1:2000)

Bcl2 Modifying Factor antibody, LS-C791287, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF. (1:2000)

Mouse Mono [LS-C791287], 1 Vial
Hu
WB

Supplier data
Lifespan Biosciences LS-C791281 Bcl2 Modifying Factor antibody, LS-C791281, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Bcl2 Modifying Factor antibody, LS-C791281, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Mouse Mono [LS-C791281], 1 Vial
Hu
WB

Supplier data
Lifespan Biosciences LS-C798398 Bcl2 Modifying Factor antibody, LS-C798398, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Bcl2 Modifying Factor antibody, LS-C798398, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY BMF. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Mouse Mono [LS-C798398], 1 Vial
Hu
WB

Supplier data
Lifespan Biosciences LS-C340304 Bcl2 Modifying Factor antibody, LS-C340304, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Bcl2 Modifying Factor antibody, LS-C340304, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Mouse Mono [OTI7B3], 1 Vial
Hu
WB

Supplier data
Lifespan Biosciences LS-C340310 Bcl2 Modifying Factor antibody, LS-C340310, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF (1:2000).

Bcl2 Modifying Factor antibody, LS-C340310, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF (1:2000).

Mouse Mono [OTI4F4], 1 Vial
Hu
WB

Supplier data
Lifespan Biosciences LS-C340303 Bcl2 Modifying Factor antibody, LS-C340303, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Bcl2 Modifying Factor antibody, LS-C340303, Lifespan Biosciences. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BMF.

Mouse Mono [OTI5H2], 1 Vial
Hu
WB

Supplier data
Boster Biological Technology M02432-1 Bcl2 Modifying Factor antibody, M02432-1, Boster Biological Technology. Western blot analysis of Bmf expression in Ramos cell lysate.

Bcl2 Modifying Factor antibody, M02432-1, Boster Biological Technology. Western blot analysis of Bmf expression in Ramos cell lysate.

Rabbit Mono [22B83], 100 ul
Hu, Mo, Rt
FACS, WB

FACS

Immunohistochemistry frozen

Supplier data
Novus Biologicals NBP2-46578 Bcl2 Modifying Factor antibody, NBP2-46578, Novus Biologicals. Immunohistochemistry: BMF Antibody (6F3) [NBP2-46578] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)

Bcl2 Modifying Factor antibody, NBP2-46578, Novus Biologicals. Immunohistochemistry: BMF Antibody (6F3) [NBP2-46578] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)

Mouse Mono [6F3], 100 ul
Hu
IHC-F, IHC-P, WB

IHC-P,

Bcl2 Modifying Factor antibody, NBP2-46578, Novus Biologicals, Western Blot image

Supplier data
Invitrogen Antibodies MA5-26878 Bcl2 Modifying Factor antibody, MA5-26878, Invitrogen Antibodies. Immunohistochemistry was performed on paraffin-embedded adenocarcinoma of human endometrium tissue. To expose target proteins, heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120°C for 3min. Following antigen retrieval, tissues were probed with a BMF monoclonal antibody (Product # MA5-26878) at a dilution of 1:150.

Bcl2 Modifying Factor antibody, MA5-26878, Invitrogen Antibodies. Immunohistochemistry was performed on paraffin-embedded adenocarcinoma of human endometrium tissue. To expose target proteins, heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120°C for 3min. Following antigen retrieval, tissues were probed with a BMF monoclonal antibody (Product # MA5-26878) at a dilution of 1:150.

Mouse Mono [OTI9B7], 100 ul
Hu
IHC-F, IHC-P, WB

IHC-P,

Bcl2 Modifying Factor antibody, MA5-26878, Invitrogen Antibodies, Western Blot image

Supplier data
Invitrogen Antibodies MA5-26907 Bcl2 Modifying Factor antibody, MA5-26907, Invitrogen Antibodies. Immunohistochemistry was performed on paraffin-embedded carcinoma of human thyroid tissue. To expose target proteins, heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120°C for 3min. Following antigen retrieval, tissues were probed with a BMF monoclonal antibody (Product # MA5-26907) at a dilution of 1:150.

Bcl2 Modifying Factor antibody, MA5-26907, Invitrogen Antibodies. Immunohistochemistry was performed on paraffin-embedded carcinoma of human thyroid tissue. To expose target proteins, heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120°C for 3min. Following antigen retrieval, tissues were probed with a BMF monoclonal antibody (Product # MA5-26907) at a dilution of 1:150.

Mouse Mono [OTI3H5], 100 ul
Hu
IHC-F, IHC-P, WB

IHC-P,

Bcl2 Modifying Factor antibody, MA5-26907, Invitrogen Antibodies, Western Blot image

Supplier data
Invitrogen Antibodies MA5-26877 Bcl2 Modifying Factor antibody, MA5-26877, Invitrogen Antibodies. Immunohistochemistry was performed on paraffin-embedded adenocarcinoma of human ovary tissue. To expose target proteins, 1 mM EDTA in 10mM Tris, pH8.5, 120°C for 3min was used. Following antigen retrieval, tissues were probed with a BMF monoclonal antibody (Product # MA5-26877).

Bcl2 Modifying Factor antibody, MA5-26877, Invitrogen Antibodies. Immunohistochemistry was performed on paraffin-embedded adenocarcinoma of human ovary tissue. To expose target proteins, 1 mM EDTA in 10mM Tris, pH8.5, 120°C for 3min was used. Following antigen retrieval, tissues were probed with a BMF monoclonal antibody (Product # MA5-26877).

Mouse Mono [OTI3E5], 100 ul
Hu
IHC-F, IHC-P, WB

IHC-P,

Bcl2 Modifying Factor antibody, MA5-26877, Invitrogen Antibodies, Western Blot image

Supplier data
Lifespan Biosciences LS-C340280 Bcl2 Modifying Factor antibody, LS-C340280, Lifespan Biosciences. IHC of paraffin-embedded Carcinoma of Human lung tissue using anti-BMF mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120

Bcl2 Modifying Factor antibody, LS-C340280, Lifespan Biosciences. IHC of paraffin-embedded Carcinoma of Human lung tissue using anti-BMF mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120

Mouse Mono [OTI9B7], 1 Vial
Hu
IHC-F, IHC-P, WB

IHC-P,

Bcl2 Modifying Factor antibody, LS-C340280, Lifespan Biosciences, Western Blot image

Supplier data
Lifespan Biosciences LS-C340278 Bcl2 Modifying Factor antibody, LS-C340278, Lifespan Biosciences. IHC of paraffin-embedded Adenocarcinoma of Human breast tissue using anti-BMF mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120

Bcl2 Modifying Factor antibody, LS-C340278, Lifespan Biosciences. IHC of paraffin-embedded Adenocarcinoma of Human breast tissue using anti-BMF mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120

Mouse Mono [OTI6F3], 1 Vial
Hu
IHC-F, IHC-P, WB

IHC-P,

Bcl2 Modifying Factor antibody, LS-C340278, Lifespan Biosciences, Western Blot image

Supplier data
Lifespan Biosciences LS-C340279 Bcl2 Modifying Factor antibody, LS-C340279, Lifespan Biosciences. IHC of paraffin-embedded Human liver tissue using anti-BMF mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120

Bcl2 Modifying Factor antibody, LS-C340279, Lifespan Biosciences. IHC of paraffin-embedded Human liver tissue using anti-BMF mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120

Mouse Mono [OTI3E5], 1 Vial
Hu
IHC-F, IHC-P, WB

IHC-P,

Bcl2 Modifying Factor antibody, LS-C340279, Lifespan Biosciences, Western Blot image

Supplier data
Lifespan Biosciences LS-C340365 Bcl2 Modifying Factor antibody, LS-C340365, Lifespan Biosciences. IHC of paraffin-embedded Human Kidney tissue using anti-BMF mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120

Bcl2 Modifying Factor antibody, LS-C340365, Lifespan Biosciences. IHC of paraffin-embedded Human Kidney tissue using anti-BMF mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120

Mouse Mono [OTI3H5], 1 Vial
Hu
IHC-F, IHC-P, WB

IHC-P,

Bcl2 Modifying Factor antibody, LS-C340365, Lifespan Biosciences, Western Blot image

Immunohistochemistry paraffin

Mouse Mono [6F3], 100 ul
Hu
IHC-F, IHC-P, WB

IHC-F,

Bcl2 Modifying Factor antibodies are often published with	Associated citations
BCL2	100.0%
Erk1	66.7%
BCL2 Like 11	33.3%
BCL2 Antagonist/Killer 1	33.3%
BCL2 Associated Agonist Of Cell Death	33.3%
Akt	33.3%
GAPDH	33.3%
Ring Finger Protein 19A, RBR E3 Ubiquitin Protein Ligase	33.3%
Protein Kinase AMP-Activated Non-Catalytic Subunit Beta 1	33.3%
p38	33.3%

Bac	Bacteria
Bt	Bat
Bv	Bovine
Cel	C.Elegans
Cml	Camel
Cn	Canine
chem	Chemical
Ch	Chicken
Dk	Donkey
Dr	Drosophila
Du	Duck
Eq	Equine
Eu	Eukaryotes
Fe	Feline
Fi	Fish
Fr	Frog
Fu	Fungus
Gt	Goat
Gf	Goldfish
GP	Guinea Pig
Ha	Hamster
Hu	Human
Inv	Invertebrates
Llm	Llama
Mam	Mammals
Mo	Mouse
Pl	Plant
Po	Porcine
Pr	Primate
Pro	Prokaryotes
Rb	Rabbit
Rt	Rat
Sh	Sheep
Sq	Squirrel
Vert	Vertebrates
Vi	Virus
Xe	Xenopus
Yt	Yeast
Zf	Zebrafish

AP	Affinity purification
Bl	Blocking
ChIP	Chromatin Immunoprecipitation
DB	Dot Blot
EMSA	Electron Microscopy
ELISA	Enzyme Linked Immunosorbent Assay
FACS	Flow Cytometry
FA	Functional Assay
GS	Gel Shift
ICC	Immunocytochemistry
ID	Immunodiffusion
IF	Immunofluorescence
IHC-F	Immunohistochemistry frozen
IHC-P	Immunohistochemistry paraffin
IP	Immunoprecipitation
IVT	In vivo targeting
Neu	Neutralising
Pep-ELISA	Peptide ELISA
PLA	Proximity Ligation Assay
RIA	Radioimmunoassay
WB	Western Blot

59 matching Bcl2 Modifying Factor monoclonal antibodies from 7 suppliers

Superstar Kits

Bcl2 Modifying Factor information

Aliases

8 Applications, 3 Species currently selected